Japan To Buy 10M More Doses Of Pfizer/Moderna COVID Jabs
Portfolio Pulse from Charles Gross
Japan is planning to purchase an additional 10 million doses of COVID-19 vaccines from Pfizer and Moderna. This move is expected to boost the country's vaccination drive and potentially benefit the mentioned companies.
October 19, 2023 | 8:52 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
BioNTech SE could see a boost in revenues from the additional vaccine sales to Japan.
The additional purchase of vaccines by Japan could lead to increased revenues for BioNTech SE. This could potentially have a positive impact on the company's stock price in the short term.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 75
POSITIVE IMPACT
The iShares MSCI Japan ETF could potentially benefit from the increased vaccination rate in Japan.
The increased vaccination rate in Japan could lead to a faster economic recovery, which could potentially have a positive impact on the iShares MSCI Japan ETF.
CONFIDENCE 70
IMPORTANCE 60
RELEVANCE 50
POSITIVE IMPACT
Moderna Inc. could benefit from the additional vaccine sales to Japan.
The additional purchase of vaccines by Japan could lead to increased revenues for Moderna Inc. This could potentially have a positive impact on the company's stock price in the short term.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 75
POSITIVE IMPACT
Pfizer Inc. could see a boost in revenues from the additional vaccine sales to Japan.
The additional purchase of vaccines by Japan could lead to increased revenues for Pfizer Inc. This could potentially have a positive impact on the company's stock price in the short term.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 75